Loading...

BioCardia, Inc.

BCDAW•NASDAQ
Healthcare
Biotechnology
$0.006
$-0.00(-3.17%)

BioCardia, Inc. (BCDAW) Stock Overview

Explore BioCardia, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.9/100

Key Financials

Market Cap10.1K
P/E Ratio-1.30
EPS (TTM)$-3.20
ROE-307.93%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.16

BCDAW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioCardia, Inc. (BCDAW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.30 and a market capitalization of 10.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;